Übersicht			Auf mobile öffnen

Lieferstatus:	i.d.R. innert 7-14 Tagen versandfertig
Veröffentlichung:	April 2014
Genre:	Naturwissensch., Medizin, Technik
	Biotechnologie / Biotechnologie - Biotechnik / Chirurgie / Endokrinologie / Krebs (Krankheit) / Onkologie / MEDICAL / Surgery / General / Medizin / Allgemeines, Einführung, Lexikon / Medizinische Grundversorgung / Neurologie / Neurologie / Neurophysiologie / Neurologie und klinische Neurophysiologie / Neurophysiologie / Onkologie - Radioonkologie / Operation (medizinisch) / Transplantation / Physiologie / Neurophysiologie / Technologie / Biotechnologie / Transplantation / Transplantationschirurgie
ISBN:	9783662035115
EAN-Code:	9783662035115
Verlag:	Springer Berlin Heidelberg
Einband:	Kartoniert
Sprache:	English
Serie:	#20 - Ernst Schering Research Foundation Workshop
Dimensionen:	H 210 mm / B 148 mm / D 11 mm
Gewicht:	261 gr
Seiten:	196
Zus. Info:	Paperback
Bewertung:	Titel bewerten / Meinung schreiben

Inhalt:

The use of cells for the treatment of a variety of diseases is no longer a dream. Today, blood transfusion, bone marrow transplantation, the use of ex vivo cultured skin in wound healing, and peripheral stern cell transplantation, including the ex vivo expansion of hematopoietic stern cells after high-dose chemo/radiation therapy, are routine. This high standard of knowledge and skills in cell transplantation might also re­ sult in tackling hitherto untreatable diseases. Organ transplantation is presently the only life-saving treatment for a variety of conditions. Important findings in cell and molecular biol­ ogy, the identification of hematopoietic, mesenchymal and neuronal stern cells, together with breakthroughs in the methodology for isolat­ ing, purifying, expanding, and storing human cells could make cellular therapy an alternative to organ transplantation in certain diseases within the next decade. Placental blood may be the source of choice in isolating naive progenitor cells for allogeneic transplantation. Immunotherapy is the most hopeful strategy to date for the treat­ ment of tumors resistant to chemotherapy, radiation therapy, or hor­ mone therapy. It includes the use of tumor-infiltrating lymphocytes, ex vivo activated memory T lymphocytes, and cell-based vaccines.